UBS cuts Schott Pharma to Neutral from Buy
Valid market news retained in the public archive without immediate LiveCast distribution.
Story updates
09:12:44 AM UTC
SquawkNews
Schott Pharma Target Cut to EUR22.30 From EUR27 by UBS